ABBV logo

ABBVAbbvie Inc

$224.77
$0.00
(0.00%)
Pre-Market
Updated: 08:05 AM EDT·Prev Close $224.77
EarningsJul 30
Mkt Cap$397.12B
Vol3,610.00

About

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
57,000

Frequently Asked Questions

What is Market Cap of Abbvie Inc?
What is the 52-week high for Abbvie Inc?
What is the 52-week low for Abbvie Inc?
What is Abbvie Inc stock price today?
What was Abbvie Inc stock price yesterday?
What is the PE ratio of Abbvie Inc?
What is the Price-to-Book ratio of Abbvie Inc?
What is the 50-day moving average of Abbvie Inc?
How many employees does Abbvie Inc have?

Advertisement|Remove ads.